COWA LLC’s AstraZeneca AZN Stock Holding History

COWA LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Sell	1,218 -16	-1%	-$3.01K	0.06%	167
2026 Q1	$243K	Sell	1,234 -1	-0.1%	-$193	0.07%	141
2025 Q4	$227K	Buy	+1,235	New	+$217K	0.07%	144
2024 Q1	–	Sell	-1,600	Closed	-$216K	–	121
2023 Q4	$216K	Sell	1,600 -2,000	-56%	-$260K	0.13%	106
2023 Q3	$488K	Sell	3,600 -690	-16%	-$94.2K	0.33%	57
2023 Q2	$614K	Sell	4,290 -17,278	-80%	-$2.54M	0.4%	54
2023 Q1	$575K	Buy	21,568 +17,218	+396%	+$2.32M	0.47%	53
2022 Q4	$636K	Sell	4,350 -510	-10%	-$64K	0.4%	55
2022 Q3	$534K	Buy	4,860 +550	+13%	+$69.8K	0.35%	61
2022 Q2	$569K	Hold	4,310	–	–	0.33%	68
2022 Q1	$572K	Hold	4,310	–	–	0.28%	69
2021 Q4	$502K	Buy	4,310 +50	+1%	+$5.88K	0.25%	71
2021 Q3	$512K	Sell	4,260 -225	-5%	-$26.2K	0.29%	67
2021 Q2	$541K	Buy	4,485 +210	+5%	+$23K	0.34%	56
2021 Q1	$427K	Buy	4,275 +580	+16%	+$58.3K	0.26%	68
2020 Q4	$375K	Buy	+3,695	New	+$391K	0.29%	68

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

COWA LLC's AZN Position: Q2 2026 in Review

COWA LLC reduced its AstraZeneca (AZN) stake by 1.3% in Q2 2026, selling an estimated $3.01K and leaving 1,218 shares worth $231K. The position accounts for 0.06% of the portfolio, ranked #167.

COWA LLC first reported a position in AZN in Q4 2020 and has held it in 16 quarters since. The position peaked at $636K in Q4 2022. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

COWA LLC held 1,218 shares of AstraZeneca worth $231K as of Q2 2026.
COWA LLC sold 16 AstraZeneca shares in Q2 2026, an estimated $3.01K.
AstraZeneca made up 0.06% of COWA LLC's portfolio in Q2 2026, its #167 holding.
COWA LLC first reported a position in AstraZeneca in Q4 2020 and has held it in 16 quarters since.
COWA LLC's AstraZeneca position peaked at $636K in Q4 2022.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on COWA LLC's 13F filing for Q2 2026, filed 6 Aug 2026.